BBR Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
1,450
-893
-38% -$137K 0.01% 236
2025
Q4
$323K Hold
2,343
0.02% 205
2025
Q3
$300K Sell
2,343
-222
-9% -$27.1K 0.02% 207
2025
Q2
$310K Hold
2,565
0.02% 181
2025
Q1
$286K Hold
2,565
0.02% 182
2024
Q4
$250K Hold
2,565
0.02% 208
2024
Q3
$295K Hold
2,565
0.02% 185
2024
Q2
$273K Sell
2,565
-4,593
-64% -$461K 0.02% 174
2024
Q1
$692K Buy
7,158
+2,959
+70% +$303K 0.06% 116
2023
Q4
$424K Buy
4,199
+1,430
+52% +$138K 0.04% 115
2023
Q3
$282K Hold
2,769
0.03% 152
2023
Q2
$279K Hold
2,769
0.03% 130
2023
Q1
$255K Buy
2,769
+204
+8% +$17.8K 0.03% 138
2022
Q4
$233K Buy
+2,565
New +$216K 0.03% 154
2022
Q3
Sell
-2,565
Closed -$217K 213
2022
Q2
$217K Hold
2,565
0.03% 193
2022
Q1
$225K Sell
2,565
-708
-22% -$61.3K 0.02% 212
2021
Q4
$286K Buy
3,273
+708
+28% +$58.8K 0.03% 162
2021
Q3
$210K Hold
2,565
0.02% 208
2021
Q2
$234K Sell
2,565
-461
-15% -$41.1K 0.02% 174
2021
Q1
$259K Sell
3,026
-2
-0.1% -$179 0.02% 177
2020
Q4
$286K Hold
3,028
0.02% 151
2020
Q3
$263K Sell
3,028
-6,128
-67% -$531K 0.02% 153
2020
Q2
$800K Sell
9,156
-5,985
-40% -$517K 0.1% 86
2020
Q1
$1.25M Sell
15,141
-2,265
-13% -$202K 0.19% 61
2019
Q4
$1.65M Buy
17,406
+12,309
+241% +$1.1M 0.18% 66
2019
Q3
$443K Buy
5,097
+171
+3% +$15.4K 0.07% 77
2019
Q2
$450K Buy
4,926
+71
+1% +$6.01K 0.07% 73
2019
Q1
$418K Sell
4,855
-11
-0.2% -$883 0.06% 97
2018
Q4
$374K Buy
4,866
+11
+0.2% +$856 0.05% 103
2018
Q3
$375K Hold
4,855
0.05% 78
2018
Q2
$329K Sell
4,855
-250
-5% -$17.3K 0.06% 77
2018
Q1
$370K Buy
+5,105
New +$389K 0.07% 65

Other funds holding NVS